End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.85 CNY | -3.06% | -1.50% | +5.91% |
May. 09 | Pacific Shuanglin Bio-pharmacy Subsidiary Gets Plasmapheresis License | MT |
Apr. 26 | Pacific Shuanglin Bio-pharmacy Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 2.97B 411M | Sales 2025 * | 3.39B 469M | Capitalization | 21.08B 2.92B |
---|---|---|---|---|---|
Net income 2024 * | 786M 109M | Net income 2025 * | 875M 121M | EV / Sales 2024 * | 7.1 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 6.22 x |
P/E ratio 2024 * |
27
x | P/E ratio 2025 * |
24.2
x | Employees | 2,426 |
Yield 2024 * |
0.35% | Yield 2025 * |
0.38% | Free-Float | 50.81% |
1 day | -3.06% | ||
1 week | -1.50% | ||
Current month | -1.50% | ||
1 month | +1.69% | ||
3 months | +11.18% | ||
6 months | +22.61% | ||
Current year | +5.91% |
Managers | Title | Age | Since |
---|---|---|---|
Ye Hong Wang
DFI | Director of Finance/CFO | 33 | 21-03-25 |
Xiao Ying Huang
BRD | Director/Board Member | 50 | 23-10-24 |
Yu Lin Zhao
SEC | Corporate Secretary | 37 | 19-05-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jun Yin
BRD | Director/Board Member | 69 | 23-10-24 |
Jin Gang Zhang
BRD | Director/Board Member | 61 | Dec. 10 |
Shao Lan Fu
CHM | Chairman | 82 | Dec. 10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 0 M€ | +3.63% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 28.85 | -3.06% | 7,528,292 |
24-05-09 | 29.76 | -0.13% | 5,880,174 |
24-05-08 | 29.8 | -0.33% | 5,262,993 |
24-05-07 | 29.9 | -1.45% | 6,891,279 |
End-of-day quote Shenzhen S.E., May 09, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.91% | 3.01B | |
-2.61% | 88.47B | |
+3.55% | 40.71B | |
-14.40% | 32.43B | |
+55.89% | 24.28B | |
-15.96% | 15.52B | |
-41.29% | 12.17B | |
-15.50% | 12.01B | |
-11.75% | 12B | |
+7.87% | 8.87B |
- Stock Market
- Equities
- 000403 Stock